Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121667) titled 'Shanghai Clinical Cohort - Leukemia (Trial Ready Cohort)' on April 1.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: The study focused on leukemia, including both acute leukemia (AL) and chronic leukemia (CL).

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-07-11

Target Sample Size: Observational group:600;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=312246

Disclaimer: Curated by HT Syndication....